Early clinical - Blog Archives

Blog

Pharmacometricians can use machine learning for PK/PD modeling to help them characterize the safety and…

CertaraMarch 4, 2025

Blog

February 28, 2025 For the past couple of decades, leading American institutions, pharmaceutical and biotechnology…

CertaraFebruary 28, 2025

Blog

February 7, 2025A key drug development safety consideration is whether the drug candidate will interact…

CertaraFebruary 7, 2025

Blog

January 10, 2025 Friedreich’s Ataxia (FA) is a rare, genetic, and progressive neurodegenerative disorder. A…

CertaraJanuary 10, 2025

Blog

December 5, 2024 What is a “cell therapy”? Nearly every recent oncology clinical conference has…

CertaraDecember 5, 2024

Blog

November 22, 2024 In drug development, early strategic planning is crucial to minimizing risks, optimizing…

CertaraNovember 22, 2024

Blog

On October 30, 2024, we hosted our Pinnacle 21 Enterprise (P21E) User Group Meeting (UGM)…

CertaraNovember 12, 2024

Blog

A symbiosis between a modeler and a trialist is often required to develop a model-informed…

CertaraNovember 8, 2024

Early clinical – Blog